Moderna on Tuesday became the latest drug company to apply to the US Food and Drug Administration forدواء Full approval of the Covid-19 vaccine For use in persons 18 years of age or older. FDA approval would allow the company to market the vaccine directly to consumers, and could also help increase public confidence in the vaccine.
Full approval can make it easier for me SchoolsAnd the The bossesgovernment agencies and the US military that has Face the resistance to corona virus vaccines, to impose vaccinations.
“We look forward to working with the FDA and will continue to provide data from the Phase 3 study and complete rolling submission,” Moderna CEO Stefan Bancel said in a statement.
Last month Pfizer and BioNTech I applied to the agency to obtain full approval for their vaccine for use in people 16 years of age or older.
Moderna vaccine was Approved for use in emergencies In December, through Sunday, more than 151 million doses were administered in the United States. According to the data From the Centers for Disease Control and Prevention.
Last week, Moderna announced that it has The vaccine appears to be very effective in adolescents And it plans to file an application for an emergency use authorization for teens in June. Pfizer vaccine was Approved for use by children between 12 and 15 years old Last month.
no modern And the Pfizer Vaccines require two fields several weeks apart, and are built around messenger RNA, the genetic material that cells read to make proteins, to help produce antibodies to the virus.
Moderna’s full approval request comes with more than 50% of the US population Received at least one dose of the vaccine, but so does the frequency of vaccinations It has fallen sharply since mid-April. recent poll from Kaiser Family Foundation مؤسسة Signs showed that Some hesitant people were persuaded: About a third of people who planned to “wait and see” if they would get the vaccine said they had scheduled or planned to do so.
“I think there were many people who were on the fence, and were worried about things moving too fast and about potential side effects,” he said. Dr. William Schaffner, Medical director of the National Foundation for Infectious Diseases and a vaccine expert. “But these fears are allayed as they see more of their friends and acquaintances celebrating the vaccination.”
Jan Hoffmann contributed reporting.
0 Comments